Dynamic Biosensors

Description

Dynamic Biosensors develops switchSENSE® and single-cell Interaction Cytometry (scIC) technologies that characterize molecular interactions to support drug discovery, immunotherapy, virology, oncology, and environmental toxicology research applications.

Dynamic Biosensors is located in the Munich ecosystem.

Related

• Tessellate BioTessellate Bio discovers and develops precision oncology small-molecule medicines based on novel synthetic lethality interactions,…
• CollimateHealthCollimateHealth develops microbeam radiation systems that deliver arrays of extremely narrow radiation beams to treat tumors while sparing…
• OncolinesOncolines provides precision medicine services in oncology and cancer immunotherapy, offering cell‑based assays, profiling platforms,…
• Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
• MaxWell BiosystemsMaxWell Biosystems provides high-density microelectrode array (HD-MEA) platforms, combining multiwell and single-well devices with software…
• KvantifyKvantify develops software and services that route calculations across quantum and classical architectures, accelerating molecular…
• CovalXCovalX characterizes therapeutic proteins and biologics using mass spectrometry services, including epitope mapping, HDX-MS, XL-MS, LC-MS,…
• EDX MedicalEDX Medical develops diagnostic tests and point-of-care devices that combine molecular biology and digital technologies to provide…
• DebiopharmDebiopharm develops and manufactures pharmaceutical drugs and invests in digital health, focusing on oncology and bacterial infections and…